U.S. Professional Services Stock News

Global markets are being pulled in different directions by inflation headlines, shifting central bank signals, and energy and trade data, so it is no surprise that many investors are focusing on companies where analysts still see solid earnings growth potential and reasonably sound balance sheets. The Healthy high growth potential screener filters for exactly that, highlighting stocks that analysts expect to grow earnings over the next 3 years while meeting basic financial strength checks. In...

In its latest update, W.W. Grainger reported a strong first quarter, raising its 2026 net sales and earnings guidance and lifting its quarterly dividend by 10%, underscoring progress in its business transformation and digital expansion across High-Touch Solutions and Endless Assortment segments. The company’s emphasis on enhanced e-commerce capabilities, supply chain investments, and improving performance in Canada highlights how its operational upgrades are reshaping the quality and...

In recent months, Alpha and Omega Semiconductor has faced concerns over insider selling of about US$2.3 million and mixed technical signals pointing to profit challenges and higher volatility. At the same time, the company’s relatively strong financial score, high institutional ownership, and overvaluation assessments are pulling investor attention toward whether its fundamentals justify current expectations. We’ll now explore how the insider selling and overvaluation concerns interact with...

WEX (WEX) has drawn investor attention after its recent share price performance, with the stock closing at US$127.53 and recording declines over the past week, month and past 3 months. See our latest analysis for WEX. Zooming out, WEX’s recent pullback, including a 14.5% decline in the 30 day share price return and an 18.7% decline over 90 days, contrasts with a 1 year total shareholder return that is also down 9.3%. This suggests momentum has been fading rather than strengthening. If you are...

Calix (CALX) is in focus after a wave of securities class action filings alleging the company misled investors about margins tied to advanced purchases of low cost memory components and subsequent negative margin pressures. See our latest analysis for Calix. At a share price of $37.95, Calix has seen weaker momentum lately, with the 90 day share price return down 24.57% and the year to date share price return down 29.18%, while the 1 year total shareholder return is down 20.11% as investors...

Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...

US regional bank stocks are back in focus after April’s Core PCE inflation reading of 3.3% and headline PCE at 3.8% put fresh attention on the Federal Reserve’s higher for longer rate stance. With policy rates now projected to stay tight into 2027 and 2028, investors are rethinking which stocks can handle extended borrowing costs and compressed equity valuations. This article looks at how that backdrop links to our US Regional Banks screener. It also walks through 3 individual stocks from the...

Madison Square Garden Entertainment (MSGE) is back in focus after multiple proposed class action lawsuits accused the company of failing to protect sensitive visitor data, including biometric facial recognition information tied to millions of venue guests. See our latest analysis for Madison Square Garden Entertainment. Despite the legal overhang, Madison Square Garden Entertainment’s recent share price return has been firm, with a 30-day share price return of 5.85% and a 90-day share price...

Earlier in June 2026, Leggett & Platt’s Leggett Dynamics unit launched its Smart Brushless Motor, a next-generation motion system designed to cut noise, vibration, and wiring complexity in automotive seating applications while improving durability and integration with modern vehicle software architectures. This launch highlights how the company is positioning itself within the shift toward software-defined, centrally controlled vehicles by offering components that can enhance in-cabin...

New York Times (NYT) has been busy reshaping its business around digital growth, from expanding The Athletic and rolling out new content verticals to refining subscription products to keep readers engaged across more formats. See our latest analysis for New York Times. Against this backdrop of dividend affirmations and digital product launches, New York Times’ share price has cooled, with a 90 day share price return down 9.77%, even as the 1 year total shareholder return of 35.67% and 3 year...

CRISPR Therapeutics (CRSP) shares have caught investor attention after recent trading, with the stock closing at US$54.09. That move comes alongside solid short term returns over the past week and month. See our latest analysis for CRISPR Therapeutics. Looking beyond the latest move, CRISPR Therapeutics shows building short term momentum, with a 7 day share price return of 8.61% and 30 day share price return of 8.40%, set against a 1 year total shareholder return of 22.24% but a weaker 5 year...

Green Brick Partners, Inc. recently appointed Eric Park, a long-time accounting professional and the company’s former Vice President, Corporate Controller, as Chief Accounting Officer and principal accounting officer, effective June 8, 2026. At the same time, institutional ownership has risen to a very high level, with major investors such as David Einhorn, BlackRock, and Dimensional Fund Advisors increasing their stakes, underscoring growing institutional involvement in the company. With...

Recent licensing deals and pipeline activity put Innoviva in focus Innoviva (INVA) has drawn attention after two recent announcements: an exclusive licensing and distribution deal for its antibiotic XACDURO with Dr. Reddy’s Laboratories, and the separate launch of Nortiva Bio, a clinical-stage subsidiary built around the LYNX drug delivery platform. See our latest analysis for Innoviva. At a share price of $22.49, Innoviva has eased slightly over the past week and day, but its year to date...

Why GEO Group Stock Is Back in Focus After ICE Detention Standard Changes GEO Group (GEO) is drawing attention after reports that U.S. Immigration and Customs Enforcement updated detention center standards in ways that reportedly reflect changes the company requested regarding language on detainee treatment. This development goes to the heart of GEO Group’s role as a government services contractor in secure facilities and immigrant detention, raising fresh questions about operational...

In mid-June 2026, Raymond James reinstated coverage on First Industrial Realty Trust with a Strong Buy rating, highlighting the REIT’s favorable mark-to-market position and upcoming leasing opportunities in the recovering industrial property market. The brokerage’s positive view on the broader industrial REIT sector, underpinned by demand related to onshoring and advanced manufacturing, frames First Industrial as a potential beneficiary of shifting supply chain and e-commerce needs. Next,...

Earlier this week, Builders FirstSource participated in a broad rally among building products companies, as investors reassessed sector conditions in housing and construction. The move, occurring without a clear company-specific trigger, highlights how shifts in sector sentiment and technical trading signals can drive trading activity for Builders FirstSource. With this backdrop of sector-wide optimism, we’ll now examine how shifting sentiment toward housing and construction could...

Earlier this week, Barclays and Wyndham Hotels & Resorts overhauled the Wyndham Rewards credit card portfolio, expanding it to four cards, adding a premium Earner Premier product, and enriching earning rates, statement credits, and elite-status benefits for cardholders. This move deepens Wyndham’s loyalty ecosystem and broadens higher-margin, fee-based credit card income streams, potentially strengthening its ancillary revenue mix and customer engagement. Next, we’ll examine how this...

With no single headline event driving PTC (PTC) today, recent share performance is front of mind for investors as the stock trades around $114.75 after a period of weaker returns. See our latest analysis for PTC. Recent trading has been choppy for PTC, with the 1-month share price return down 21.32% and the year-to-date share price return down 32.54%, while the 1-year total shareholder return has declined 31.28%. This suggests that momentum has been fading rather than building. If you are...

Franklin Electric recently reported past quarterly results showing revenue up 9.93% year-over-year and net profit up 10.91%, with a financial health score of 7.04 and average operating efficiency versus peers. At the same time, bullish technical indicators pointing to a buy signal and strong price momentum highlight how current trading trends are aligning with the company’s healthier fundamentals. Now we’ll examine how this combination of solid quarterly revenue and profit growth may...

Enact Holdings (ACT) just delivered quarterly revenue ahead of expectations, yet the stock moved lower after the earnings release, underscoring how mixed signals in the report shaped investor reaction. See our latest analysis for Enact Holdings. At a share price of $42.39, Enact Holdings has seen short term share price momentum soften over the past month, even as the 1 year total shareholder return of 19.41% and 3 year total shareholder return of 87.26% point to a longer track record that...

Select Water Solutions (WTTR) has drawn fresh attention after recent trading, with the stock closing at $17.70. Investors are weighing this price against the company’s latest financial profile and longer term return record. See our latest analysis for Select Water Solutions. While Select Water Solutions’ share price has slipped 1.9% over the past day and 6.4% over the past week, the 90 day share price return of 22.8% alongside a 1 year total shareholder return of 96.6% points to stronger...

Syndax Pharmaceuticals recently reported that Phase 1/2 SAVE trial data for its all-oral regimen combining Revuforj (revumenib), decitabine/cedazuridine, and venetoclax in heavily pretreated relapsed or refractory AML were published in the Journal of Clinical Oncology and presented at the 2026 European Hematology Association Congress. The regimen’s high overall and composite complete remission response rates across NPM1m, KMT2Ar, and NUP98r subgroups, together with meaningful MRD-negativity...

In early June 2026, a federal judge in Oregon denied motions to dismiss a class-action lawsuit alleging that Lamb Weston and other operators contributed to nitrate contamination of groundwater in the Lower Umatilla Basin, allowing claims under federal RCRA and Oregon law for negligence, trespass, nuisance, and medical monitoring to proceed toward a jury trial scheduled for May 2027. This ruling heightens legal and reputational risk for Lamb Weston, particularly because the case centers on...

In recent months, First BanCorp reported an elite 4.6% net interest margin and saw analysts revise earnings estimates upward for the current and next fiscal years, reinforcing confidence in its lending profitability and earnings outlook. Despite softer longer-term net interest income growth and a shrinking loan book, the bank’s strong margin profile and positive estimate revisions have supported favorable analyst rankings and sustained momentum signals. Building on these developments, we'll...